Feb 04 2025
Dr. Jay Duker joins the program to discuss his transition from chair of an ophthalmology department to President & CEO of Eyepoint Pharmaceuticals.
Disclosures: Dr. Duker is President & CEO of Eyepoint Pharmaceuticals. Dr. Sridhar has consulted for Eyepoint Pharmaceuticals.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi